Provider: View Press Release
Type: Microsoft
Title: GSK and Microsoft, in collaboration with the Centre for Health and Disease Studies, launch disease surveillance project in Nepal | GSK
Description: New partnership combines expertise across Biopharma and Tech sectors.
Provider: View Press Release
Type: Link
Title: GSK launches Sustainable Procurement Programme for suppliers | GSK
Description: From 2023, the company will require and support suppliers to take action on sustainability commitments.
Provider: View Press Release
Type: Link
Title: Zejula (niraparib) shows durable and sustained long-term progression-free survival benefit in the PRIMA study of first-line platinum-responsive advanced ovarian cancer | GSK
Description: GSK today announced long-term data from the phase III PRIMA study
Provider: View Press Release
Type: Link
Title: GSK announces update on US FDA regulatory review of daprodustat in anaemia of chronic kidney disease | GSK
Description: GSK today announced that the US FDA will convene a meeting of the Cardiovascular and Renal Drugs Advisory Committee to review daprodustat
Provider: View Press Release
Type: Link
Title: WHO grants prequalification to GSK’s Mosquirix – the first and only approved malaria vaccine | GSK
Description: An important step for rolling out the vaccine to children living in regions with moderate to high transmission.
Provider: View Press Release
Type: Link
Title: GSK to highlight the latest advances in cancer research from across its portfolio and pipeline at ESMO | GSK
Description: GSK will present new findings from across its diverse oncology portfolio and pipeline at the congress.